BRUSSELS (Reuters) - The European Commission said on Thursday it had reached a temporary agreement with South Africa to use a plant there to bottle Johnson & Johnson COVID-19 vaccines that are being imported into the EU.
On Wednesday the WHO Director-General Tedros Adhanom Ghebreyesus told reporters he was "stunned" by news that J&J vaccines were being exported from South Africa to the EU, because the EU has already very high vaccination rates while in many African countries not even the most vulnerable have been vaccinated.